Keyword Analysis & Research: a2a pharmaceuticals
Keyword Research: People who searched a2a pharmaceuticals also searched
Search Results related to a2a pharmaceuticals on Search Engine
-
HOME | A2APHARMA.COM
https://www.a2apharma.com/
WEBAt A2A Pharmaceuticals, our mission is to leverage proprietary computational systems, including A.I., to accelerate development of novel drug alternatives for life threatening diseases like cancer, bacterial infections and muscular dystrophy. RECENT A2A NEWS. Significant Achievements to Date. 2020.
DA: 73 PA: 12 MOZ Rank: 47
-
Oncology & Autoimmune | A2APHARMA.COM
https://www.a2apharma.com/copy-of-pipeline-1
WEBONCOLOGY & Autoimmune. MLL-MENIN INHIBITORS. Targeting the menin-MLL interaction with small molecules represents an attractive strategy to develop a new anticancer in genetically defined populations of leukemias and in certain solid cancer.
DA: 2 PA: 33 MOZ Rank: 58
-
LEADERSHIP | A2APHARMA.COM
https://www.a2apharma.com/team
WEBHarvard Medical School, Bayer, Novartis, Celgene, CMO of Ipsen . Chief Medical Officer, SVP and Head of Global Medical Affairs at Ipsen. Vice President and Head of Global Medical Affairs Oncology for Baxalta Inc and Shire & roles in medical affairs and clinical development at Bayer Pharmaceuticals, Novartis Pharmaceuticals and Celgene …
DA: 68 PA: 72 MOZ Rank: 14
-
A2A Pharmaceuticals | LinkedIn
https://www.linkedin.com/company/a2a-pharmaceuticals
WEBA2A Pharmaceuticals designs computationally optimized small molecule therapeutics for the treatment of cancer and antibiotic resistant bacterial infections. Our two oncology programs are...
DA: 18 PA: 99 MOZ Rank: 95
-
A2A Pharmaceuticals Inc. Today Announced a Multi-target Co …
https://www.businesswire.com/news/home/20200113005978/en/A2A-Pharmaceuticals-Inc.-Today-Announced-a-Multi-target-Co-development-Agreement-With-Daewoong-Pharmaceutical-for-AI-enhanced-Oncology-Drug-Discovery
WEBJan 14, 2020 · - A2A Pharmaceuticals Inc. is committed to the development of new therapeutic agents that serve highly unmet patient needs. Our focus area is oncology and a program for Duchenne’s Muscular...
DA: 98 PA: 84 MOZ Rank: 39
-
A2A Pharmaceuticals Collaborates With LAXAI Life Sciences to …
https://www.prnewswire.com/news-releases/a2a-pharmaceuticals-collaborates-with-laxai-life-sciences-to-co-develop-sars-cov-2-main-proteases-inhibitors-for-the-treatment-of-covid-19-301072123.html
WEBHYDERABAD, India, June 8, 2020 /PRNewswire/ -- A2A Pharmaceuticals, a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents announces...
DA: 91 PA: 72 MOZ Rank: 42
-
A2A Pharmaceuticals - Crunchbase Company Profile & Funding
https://www.crunchbase.com/organization/a2a-pharmaceuticals
WEBDetails. A2A Pharmaceuticals Inc. is a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents. Their focus is on the development of novel drugs to treat antibiotic resistant bacterial infections and address unmet needs in cancer.
DA: 43 PA: 6 MOZ Rank: 74
-
A2A Pharmaceuticals | BIO
https://www.bio.org/policy/human-health/vaccines-biodefense/coronavirus/a2a-pharmaceuticals
WEBA2A Pharmaceuticals is testing the use of selective covalent SARS-CoV-2 MPro inhibitors for COVID-19 patients.
DA: 6 PA: 20 MOZ Rank: 23
-
A2A Pharmaceuticals - Company info. interviews, news
https://www.biopharmatrend.com/m/company/a2a-pharmaceuticals/
WEBAug 18, 2022 · A2A Pharmaceuticals designs computationally optimized small molecule therapeutics for the treatment of cancer and antibiotic resistant bacterial infections. Our two oncology programs are focused on inhibiting essential protein-protein interactions in leukemia and in diverse solid tumors.
DA: 29 PA: 69 MOZ Rank: 71
-
NEWS | A2APHARMA.COM
https://www.a2apharma.com/blog
WEBMay 22, 2023. FDA Clearance of IND Application for TACC3 PPI Inhibitor A2A-252 in Women's Cancer. A2A Pharma. Jan 13, 2021. A2A co-founded biomea Fusion raises $56M.
DA: 94 PA: 13 MOZ Rank: 27
